When we divided all CD3+ cells into the different T-cell subpopulations, we observed that >80% of the CD3+ T cells were either CD4+ or CD8+ in both tumour and uninvolved pancreatic tissues (Fig. 3j, middle panel). The gene discussed is CD4; the disease is neoplasm.